Daiichi Sankyo Co Ltd - Company & Market Research Reports

Home /
Companies /
Daiichi Sankyo Co Ltd

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 117
Cardiovascular Drugs 93
Drug Discovery 65
Vaccines 48
Central Nervous System Drugs 45
Endocrine and Metabolic Disorders Drugs 37
Hematological Drugs 34
Infectious Diseases Drugs 33
Pharmaceuticals 31
Clinical Trials 29
Immune Disorders Drugs 28
Leukemia Drugs 28
Musculoskeletal Disorders Drugs 28
Genomics 25
Analgesics 23
Biopharmaceuticals 23
Skin Cancer Drugs 18
Contrast Media 16
Oncology 16
Diabetes Drugs 15
Lung Cancer Drugs 15
Infusions and Injectables 15
Liver and Kidney Disorders Drugs 15
Antibiotics 15
Biotechnology 14
Women's Health 14
Brain Cancer Drugs 12
Allergy and Immunology 11
Breast Cancer Drugs 11
Enzymes 11
Diagnostics 11
Gastrointestinal Drugs 11
Hematology 10
Alzheimer's Disease Drugs 10
Respiratory Drugs 9
Biosimilars and Biosuperiors 9
Pharmaceutical Manufacturing 9
Cardiology 8
Healthcare Services 7
Colon Cancer Drugs 7
Animal Pharmaceuticals 6
Infectious Disease Testing 6
Urological Disorders Drugs 6
Optical Disorders Drugs 5
Pulmonary Medicine 5
Neurology 5
Liver Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Managed Care 5
Stem Cells 5
Thyroid Cancer Drugs 5
Dermatological Drugs 5
Pharmaceutical Intermediates 4
Therapeutic Area 4
Cervical Cancer Drugs 4
In Vitro Diagnostics 4
Ultrasound 4
Drug Delivery 4
Pancreatic Cancer Drugs 4
Gastroenterology 4
Drugs by Therapeutic Area 3
Prostate Cancer Drugs 3
Transdermal and Transmucosal Drug Delivery 3
Medical Devices 3
Neurology Devices 3
Anti-Obesity Drugs 3
HIV/AIDS Drugs 3
Addiction Disorders Drugs 2
Company Reports 2
Urology and Nephrology 2
Generic Drugs 2
Bladder Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
Blood Banking 2
Anesthetic Drugs 2
Needles and Syringes 2
Over the Counter (OTC) Drugs 2
Nuclear Medicine and Radiopharmacology 2
Cancer Vaccines 2
Laboratory Equipment 2
Palliative Care 2
Pediatrics 2
Acne Drugs 2
Bronchitis Drugs 2
Schizophrenia Drugs 2
Patient Monitoring Equipment 1
Pharmacoeconomics 1
Medical Imaging 1
Hospital Information Systems 1
Coagulation and Hemostasis Testing 1
Healthcare 1
Dental 1
Magnetic Resonance Imaging (MRI) 1
Radiography 1
Diabetes Devices 1
Optical 1
Hospital Management 1
Biomarkers 1
Dermatology 1
Surgical Procedures 1
Molecular Diagnostics 1
Catheters 1
Mental Disorders Drugs 1
Uterine Cancer Drugs 1
Vitamins and Dietary Supplements 1
Other Healthcare Facilities 1
Nanomedicine 1
Endocrinology 1
Asthma Drugs 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

820 Results (Page 32 of 41)
- Relevance
  Sort by

Company Snapshots: Japan Pharmaceutical

 Newsletter
August 2025
35 Pages
Japan

From

€215EUR$240USD£187GBP

Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7107EUR$7,950USD£6,183GBP

Antithrombotic Drugs - Global Strategic Business Report

 Report
August 2025
282 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Stem Cell Manufacturing Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4014EUR$4,490USD£3,492GBP

Iron Drugs - Global Strategic Business Report

 Report
August 2025
187 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Gastric Motility Disorder Drugs - Global Strategic Business Report

 Report
August 2025
371 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Duodenal Ulcer Treatment - Global Strategic Business Report

 Report
August 2025
380 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Alport Syndrome Market by Treatment Type, End User, Distribution Channel, Patient Age Group, Disease Stage, Insurance Type - Global Forecast to 2030

 Report
May 2025
181 Pages
Global

From

€3169EUR$3,545USD£2,757GBP

€3521EUR$3,939USD£3,064GBP

Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028

 Report
October 2024
126 Pages
Asia Pacific

From

€2235EUR$2,500USD£1,944GBP

DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035

 Report
October 2023
278 Pages
Global

From

€4290EUR$4,799USD£3,733GBP

Global Menin Inhibitor Drugs Clinical Trials & Future Opportunity Insight 2023

 Report
September 2023
75 Pages
Global

From

€2655EUR$2,970USD£2,310GBP

€2950EUR$3,300USD£2,567GBP

Neuroprotection Market by Indication, Product Type, Mechanism of Action, Distribution Channel, End User - Global Forecast to 2030

 Report
May 2025
199 Pages
Global

From

€3169EUR$3,545USD£2,757GBP

€3521EUR$3,939USD£3,064GBP

Ewings Sarcoma Treatment Market 2025-2029

 Report
December 2024
197 Pages
Global

From

€2235EUR$2,500USD£1,944GBP

Human Combination Vaccines Market 2025-2029

 Report
May 2025
222 Pages
Global

From

€2235EUR$2,500USD£1,944GBP

Enzyme Inhibitors - Global Strategic Business Report

 Report
August 2025
376 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Central Nervous System Collaboration and Licensing Deals 2020-2025

 Report
April 2025
400 Pages
Global

From

€3571EUR$3,995USD£3,107GBP

Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

 Report
September 2022
799 Pages
Global

From

€4290EUR$4,799USD£3,733GBP

Vaccines Market 2025-2029

 Report
January 2025
194 Pages
Global

From

€2235EUR$2,500USD£1,944GBP

Influenza Vaccine Market by Vaccine Type, Distribution Channel, End User, Age Group, Dosage, Presentation - Global Forecast to 2030

 Report
May 2025
190 Pages
Global

From

€3169EUR$3,545USD£2,757GBP

€3521EUR$3,939USD£3,064GBP

Antibody Therapeutics - Global Strategic Business Report

 Report
August 2025
577 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

820 Results (Page 32 of 41)
- 1
- 30
- 31
- 32
- 33
- 34

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.